Stock COCRYSTAL PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cocrystal Pharma Inc OTC Bulletin Board

Equities

US19188J1025

Chart calendar Cocrystal Pharma Inc

6.4HGw7R6Of7eDSIho1jki1-NqeljrFcfEp7UcdUBIYeY.ihTytHC3L4bCetACn2oXopAjERPTT4Kd9cFVQh8xUpOLKPmVLeIMg_oLxQ~f9e3300bc02699fa3e9e6eddc01dbac9

Upcoming events on Cocrystal Pharma Inc

2024-06-25 11:00 am Annual General Meeting
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-04-06 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)

Past events on Cocrystal Pharma Inc

2024-05-13 08:00 am Q1 2024 Earnings Release
2024-03-28 08:00 am Q4 2023 Earnings Release
2023-12-04 01:30 pm Noble Capital Markets Emerging Growth Equity Conference
2023-11-26 World Vaccine Congress
2023-11-15 Channelchek C-Suite Interview Series
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 08:00 am Q2 2023 Earnings Release
2023-06-08 02:00 pm Annual General Meeting
2023-05-15 08:00 am Q1 2023 Earnings Release
2023-05-04 02:05 pm International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Conference
2023-03-29 10:30 am Investor Summit
2023-03-29 08:00 am Q4 2022 Earnings Release
2023-02-02 11:30 am Sequire Biotechnology Conference
2023-01-31 Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference
2022-12-01 11:10 am World Antiviral Congress
2022-11-14 11:30 am FY Investor Summit
2022-11-14 08:00 am Q3 2022 Earnings Release
2022-11-03 02:05 pm BioFlorida Conference
2022-10-26 06:30 pm LD Micro Main Event Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		2,01
2,08
-3.06%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-18,4
-19,7
6.95%
-20,6

EBIT
Million USD		Released
Forecast
Spread 		-8,87
-9,14
3.02%		-9,59
-11,0
13.13%		-14,2
-14,4
1.37%		-38,8
-40,1
3.23%		-18,6
-19,8
6.07%
-21,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-14,2
-14,4
1.49%		-38,8
-40,1
3.24%		-18,0
-19,2
6.55%
-20,7

Net income
Million USD		Released
Forecast
Spread 		-48,2
-6,19
-678.43%		-9,65
-10,7
9.83%		-14,2
-14,4
1.49%		-38,8
-40,1
3.24%		-18,0
-19,2
6.55%
-20,7

EPS
USD		Released
Forecast
Spread 		-18,1
-2,28
-694.74%		-2,04
-2,40
15%		-1,92
-1,92
0%		-4,77
-4,93
3.25%		-1,87
-2,09
10.67%
-2,02

Announcement Date27/03/2017/03/2123/03/2229/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,63
- 		0,00
0,08
- 		0,00
0,08
- 		0,00
0,00
- 		0,00
0,17
- 		0,00
0,27
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,21
-3,50
-20.14%		-3,74
-4,20
11.05%		-5,69
-4,10
-38.88%		-4,50
-5,80
22.38%		-5,11
-4,50
-13.58%		-5,20
-5,30
1.91%		-4,44
-4,60
3.41%		-4,67
-5,88
20.65%		-4,16
-5,55
25.08%
-5,20


-5,60


-6,03







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,21
-3,50
-20.23%		-24,4
-4,20
-481.62%		-5,70
-4,10
-39.02%		-4,50
-5,80
22.4%		-5,19
-4,50
-15.31%		-5,03
-5,30
5.17%		-4,17
-4,60
9.46%		-4,46
-5,88
24.08%		-3,96
-5,50
28.07%
-5,15


-5,55


-5,98







Net income
Million USD		Released
Forecast
Spread 		-4,21
-3,50
-20.23%		-24,4
-4,20
-481.62%		-5,70
-4,10
-39.02%		-4,50
-5,80
22.4%		-5,19
-4,50
-15.31%		-5,03
-5,30
5.17%		-4,17
-4,60
9.46%		-4,46
-5,88
24.08%		-3,96
-5,50
28.07%
-5,15


-5,55


-5,98







EPS
USD		Released
Forecast
Spread 		-0,48
-0,48
0%		-3,00
-0,54
-455.56%		-0,70
-0,49
-42.86%		-0,54
-0,71
23.94%		-0,64
-0,59
-8.47%		-0,50
-0,53
4.76%		-0,41
-0,53
22.64%		-0,44
-0,60
26.26%		-0,39
-0,54
27.78%
-0,51


-0,55


-0,59


-0,63


-0,45

Announcement Date11/05/2215/08/2214/11/2229/03/2315/05/2314/08/2313/11/2328/03/2413/05/24-----

Upcoming sector events for Cocrystal Pharma Inc

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Cocrystal Pharma Inc

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. COCP Stock
  4. Stock
  5. Calendar Cocrystal Pharma Inc